Results 281 to 290 of about 239,171 (312)

Duodenal Amyloidosis Inducing Malabsorption in Hepatitis B-Related Liver Cirrhosis: A Rare Case Presentation. [PDF]

Cureus
Ghosh CK, Sarker A, Islam S, Islam N, Chowdhury P, Islam M, Bari A.   +6 more
europepmc   +1 more source

The mediating role of social support in self-management and quality of life in patients with liver cirrhosis. [PDF]

Sci Rep
Zhang Y, Xiao L, Liu Q, Zhang X, Li M, Xu Y, Dai M, Zhao F, Shen Y, Salvador JT, Yang P.   +10 more
europepmc   +1 more source

Targeting Hepatic Stellate Cells for the Prevention and Treatment of Liver Cirrhosis and Hepatocellular Carcinoma: Strategies and Clinical Translation. [PDF]

Pharmaceuticals (Basel)
Xiong H, Guo J.
europepmc   +1 more source

A Comparative Study of Dietary Intake, Nutritional Status, and Frailty in Outpatients and Inpatients with Liver Cirrhosis. [PDF]

Nutrients
Khan S, Sansoni S, Di Cola S, Lapenna L, Merli M.   +4 more
europepmc   +1 more source

Mitigating renal dysfunction in liver cirrhosis: Therapeutic role of ferrous sulphate, folic acid, and its co-administration. [PDF]

Toxicol Rep
Dash D, Rai RK, Koiri RK.
europepmc   +1 more source

The therapeutic effect of leucogen in treating alcoholic liver cirrhosis with thrombocytopenia or leukopenia. [PDF]

Ann Saudi Med
Su M, He M, Yang WC, Wang J, Guo C, Fu YM, Chun-Wang, Li S, Ji D, Chen HY.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Liver cirrhosis

The Lancet, 2021
Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C infection, autoimmune diseases, cholestatic diseases, and iron or copper overload.
Ginès, Pere, Krag, Aleksander, Abraldes, Juan G., Solà, Elsa, Fabrellas, Núria, Kamath, Patrick S.   +5 more
openaire   +3 more sources